No NIH-funded research grants were found for Spinal Muscular Atrophy, Type Iv in the last 36 months.
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Spinal Muscular Atrophy, Type Iv. Largest gap: Epidemiology / Natural History.
1 clinical trial registered but no NIH-funded clinical or translational research grants found for spinal muscular atrophy, type IV. Trials may be industry-sponsored or funded through non-NIH sources.
5 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for spinal muscular atrophy, type IV. Existing research activity suggests this may be a viable area for grant applications.
6 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for spinal muscular atrophy, type IV. Existing research activity suggests this may be a viable area for grant applications.
5 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for spinal muscular atrophy, type IV. Existing research activity suggests this may be a viable area for grant applications.
No NIH-funded research found for Spinal Muscular Atrophy, Type Iv
No grants were found in the NIH RePORTER database for the last 36 months. This is common — many rare diseases lack dedicated NIH funding. NIH RePORTER covers NIH, FDA, and CDC grants only; private foundations, industry, and international funders are not included.
Track funding opportunities for Spinal Muscular Atrophy, Type Iv.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.